Home | BioLizard

Who we work with

We support biotech, pharmaceutical and diagnostic companies, and research institutions of all sizes to enable truly data-driven discovery, preclinical, translational and clinical R&D processes. We also have robust experience working in the animal health field as well as in supporting food and agriculture R&D.

What we do

Leveraging our expertise in advanced bioinformatics, predictive analytics & AI, tailored software development, and data governance & architecture to support you in data-driven research and development and (pre)clinical studies.

Learn more →

How we do it

BioLizard brings together a diverse yet complementary range of expertises to implement the most up-to-date technological tools to meet your unique data needs, now and in the future. We believe that an inclusive and open communication strategy with our clients is essential for the successful completion of each project. We ensure to align regularly with you throughout the process, and adjust pipelines to best fit your unique data case and maximize your output.

When you partner with BioLizard, you get state-of-the-art data analysis pipelines and tools to apply to your current and future research projects - and moreover, you receive end-to-end support that will make it faster and easier for you to turn your data into actionable insights. We also always ensure to fully explain our data science approach to solving your biological challenges - there’s no black box when you work with BioLizard.

Watch our free webinar

Watch our in-depth webinar delving into the cutting-edge realm of spatial omics technologies.

In this webinar, experts from BioLizard and Pixelgen Technologies guide you through how spatial omics can deepen your biological understanding by preserving spatial context within molecular analyses.

Watch now →

BioLizard featured on Hub & Spoken podcast

Volodimir Olexiouk, our Director of Scientific Engagement and Data Science Team Lead, was featured in episode 205 of Cynozure's Hub & Spoken podcast.

In this episode, host and CEO Jason Foster speaks with Volodimir about the revolutionary intersection of artificial intelligence and pharmaceuticals, exploring how AI is transforming the landscape of drug discovery.

Listen now →

Cynozure_Hub&Spoken_Ep.205-Volodimir Olexiouk

BioLizard announces Swiss subsidiary

We are proud to announce that we have made an exciting new step in our continued international expansion, while deepening our commitment to our current and future Swiss partners and clients.

With the opening of our newest office at Biopôle Lausanne, we have officially entered the Swiss market. Biopôle, which houses 120 companies, provides the perfect conditions for us to engage with the Swiss biotech industry and offer our services exactly where our clients need them.

Read more →

BioLizard and AbnomX announce partnership

We are happy to announce our strategic partnership with AbnomX.

BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data.

Read more →

BioLizard featured on Data Science Leaders podcast

Volodimir Olexiouk, our Director of Scientific Engagement and Data Science Team Lead, was featured in episode 70 of Domino Data Lab's Data Science Leaders podcast.

In this episode, host Kjell Carlsson speaks with Volodimir about best practices for overcoming the data challenges for AI-driven drug discovery and combining scientific expertise with data science for augmented intelligence in the life sciences.

Listen now →

Domino Data Science Leaders Podcast episode 70

BioLizard Highlighted at Bio-EUROPE

"It's not trivial to make sure that you have your data (management) right, to then be able to apply advanced analytics."

MC Services interviewed our BD Director Amparo Cuéllar at Bio-EUROPE. Check out the 2-minute video wherein she discusses:

The importance of ensuring that application of AI and other advanced analytics is grounded in an understanding of biology and your business strategy
Data analytics trends in the life sciences
What's next for BioLizard
Advice for companies who want to become more data-driven

Watch the 3-minute video →